Abstract:Background Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme in the metabolism of folate. The non-synonymous single nucleotide polymorphism (nsSNP), C677T (Ala>Val, rs1801133), has been verified to impair enzyme activity. The association with cancer susceptibility, including hepatocellular carcinoma (HCC), has also been widely studied. The results, however, were inconsistent. To shed light on the influence of MTHFR C677T polymorphism on HCC, a meta-analysis was conducted. Methods The meta-analysis of C677T consisted of 10 studies (1814 cases/2862 controls). The association was measured by using random-effect (RE) or fixed-effect (FE) odds ratio (OR) combined with 95% confidence intervals (CIs) according to the studies' heterogeneity. Results Using genetic model analysis, C677T polymorphism was found to increase the risk of HCC in a complete overdominant model, which indicates that heterozygotes CT are at a lesser risk of HCC than either homozygotes CC or TT. Meta-analyses of the 10 studies showed that the TT genotype increased the risk of HCC as compared to the CT genotype: FE OR was 1.20 (95%CI: 1.00-1.45, p for heterogeneity = 0.21). When subgroup analysis was done between the HCC cases and the chronic liver disease (CLD) patients of four studies, meta-analysis showed that individuals with the TT genotype had increased HCC risk compared with those with the CT genotype: FE OR (TT vs. CT) reached 1.81 (1.22-2.71, p for heterogeneity = 0.25). Meanwhile, the C677T polymorphism also increased HCC risk in a recessive model when cases were compared to CLD patients of four studies: RE OR reached 1.85 (95%CI: 1.00-3.42, p for heterogeneity = 0.06). Overall, there was some extent heterogeneity when analyses were performed in various models. There was no publication bias. Conclusion MTHFR C677T polymorphism increased the risk of HCC in an overdominant model, and might be a risk factor for HCC occurrence, especially in CLD patients. The association warranted further studies.

Exploration on the relationship between MTHFR(5,10-methylenetetrahydrofolate reductase) gene polymorphisms and the risk of primary liver cancer

Association Between the MTHFR A1298C Polymorphism and Risk of Cancer: Evidence from 265 Case–control Studies

FOLIC ACID,METHIONINE,AND POLYMORPHISMS OF METHYLENETETRAHYDROFOLATE REDUCTASES AND SUSCEPTIBILITY OF COLORECTAL CANCER

Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer.

Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary Hepatocellular Carcinoma (HCC) in a Chinese population

Meta-analysis on the Relationship Between MTHFR Gene Polymorphisms and Colorectal Cancer

Relationship between MTHFR C677T Polymorphisms and Susceptibility of Digestive System Cancer and Coronary Heart Disease

[Association Between Genetic Polymorphisms in Folate Metabolic Enzyme Genes and Colorectal Cancer: a Nested Case-Control Study].

5,10-Methylenetetrahydrofolate reductase ( MTHFR ), methionine synthase ( MTRR ), and methionine synthase reductase ( MTR ) gene polymorphisms and adult meningioma risk

Genetic Polymorphism of MTHFR C677T Influences Susceptibility to HBV-Related Hepatocellular Carcinoma in a Chinese Population: a Case-Control Study

Mthfr C677t Polymorphism And Risk Of Congenital Heart Defects: Evidence From 29 Case-Control And Tdt Studies

[A Case-Control Study on the Association Between Genetic Polymorphisms of Metabolic Enzymes and the Risk of Colorectal Cancer].

The combined effect of MTHFR C677T and A1298C polymorphisms on the risk of digestive system cancer among a hypertensive population

Association Between the Methylenetetrahydrofolate Reductase C677T Polymorphism and Hepatocellular Carcinoma Risk: a Meta-Analysis

The Methylenetetrahydrofolate Reductase ( MTHFR ) C677T Polymorphism and Tumor Risk: Evidence from 134 Case–control Studies

A Case-Control Study on the Polymorphisms of Methylenetetrahydrofolate Reductases, Drinking Interaction and Susceptibility in Colorectal Cancer

MTHFR C677T polymorphism contributes to the risk for gastric cancer

[Association Between Genetic Variations in Methylenetetrahydrofolate Reductase and Risk of Colorectal Cancer in a Chinese Population].

Aberrant DNA methylation of the P16, MGMT, and hMLH1 genes in combination with the methylenetetrahydrofolate reductase C677T genetic polymorphism and folate intake in gastric cancer

Relationship Between Polymorphisms of Thymidylate Synthase and Methylenetetrahydrofolate Reductase and Susceptibility in Liaoning Benxi Colorectal Cancer Patients

The polymorphism of methylenetetrahydrofolate reductase C677T but not A1298C contributes to gastric cancer